2025 Annual Meeting Session Recordings
Below are links to selected session recordings from the MASCC/ISOO 2025 Annual Meeting. Please note that not all presentations are included.
Plenary Presentations
Plenary 1 – Financial Toxicities: Time for a Change at the Global Level
Chairs: Prof. Raymond Chan & Prof. Gary Lyman
Presentations:
Financial Toxicity: From Data to Practice and Policy Change – Dr. Fumiko Chino
Financial Toxicity in Cancer Supportive Care: A MASCC Survey – Prof. Alexandre Chan
Current Solutions to Mitigate Financial Toxicity in LMICs – Jennifer Dent
Plenary 3 – Repurposing Medications For New Approaches to Supportive Care
Chairs: Prof. Joel Epstein & Prof. Joanne Bowen
Presentations:
Opportunities and Challenges of Drug Repurposing in Cancer Supportive Care – Prof. Moran Amit
Role for Hormones and Other Non-pharmacological Approaches in Advanced Cancer – Prof. Jose Garcia
Advancing the Science in Hard to Manage Symptoms of Cancer and Its Treatment: Focus on Neuroactive Agents – A/Prof. Hannah Wardill
Plenary 2 – Emerging Toxicities of Emerging Treatments
Chairs: Prof. Christina Ruhlmann & Prof. Eric Roeland
Presentations:
What Do We Need to Know About Emerging Treatment Toxicities? – Prof. Hope Rugo
Specific Emerging Toxicities of Concern: Mechanisms and Management of ADC-Related Lung Toxicity – Dr. Greta Bridwell
Role of the Microbiome in Modulating Toxicities to Emerging Treatments – Prof. Lisa Derosa
Joint Sessions
Tackling Cancer Cachexia With a Multidisciplinary Team: A New Perspective Through Collaboration (JASCC, KASCC & MASCC Joint Session)
Chairs: Prof. Egidio Del Fabbro & Tateaki Naito
Presentations:
Bridging the Gap in Cancer Cachexia Management: The Role of Pharmacists, Educational Needs, and Insights from the GENESIS-CC Study – Hironori Fujii
The Role of Dietitians in Cancer Cachexia: The Impact of Early Nutritional Interventions on Cancer Patients – Dr. Kate Furness
Exercise and Nutrition in Cancer Patients During Chemotherapy – Dr. In Gyu Hwang
Skeletal Muscle Loss and Associated Clinical Outcomes in Small Cell Lung Cancer Patients Receiving Concurrent Chemoradiation – Dr. Song Ee Park
GDF15 Levels and Clinical Correlates in Head and Neck Cancer Patients: Developing a Risk Model for Cachexia – Dr. Connor Williams
Skeletal Muscle Quantity and Quality at Diagnosis and Overall Survival in Young Women With Breast Cancer – Asst Prof. Aynur Aktas
Cultural Differences: The Stigma When Cancer is Visible
Chairs: Dr. Corina van den Hurk & Dr. Fatma Ben Abid
Presentations:
Visible Stigma in Cancer in LMIC: The Moroccan Experience – Dr. Mounir Bachouchi
May Cardiovascular Toxicity Also Be Stigmatizing in a Cancer Patient? – A/Prof. Sebastian Szmit
Cancer and Its Treatment, How Do the Indians React? A Stigma or a Sympathy – Prof. Vikas Ostwal
Challenges of Supportive Care for Cancer in Resource-limited Countries – Dr. Yervand Hakobyan
The Open-Minded, Free-Spoken Dutch: What if Cancer is Visible? – Dr. Corina van den Hurk
Let’s Expand the Toolbox With Integrative Oncology in Supportive Care, in Partnership With SIO
Chairs: A/Prof. Judith Lacey & Dr. Po-Ju Lin
Presentations:
Emerging and Chronic Toxicities and the Role of IO in Management. A Multidisciplinary Approach to Complex Symptoms and Symptom Clusters for People Affected by Cancer – A/Prof. Judith Lacey
Acupuncture for Neurological Toxicity Related to Cancer Therapy: The Example of CIPN – Dr. Ting Bao
Informed Decisions in Supportive Cancer Care: The Importance of Guidelines and SIO-ASCO Partnership in Moving the Field of IO in SC Forward – Dr. Heather Greenlee
Treatment of Depressive Symptoms in Fatigued Ovarian Cancer Survivors With Self-administered Acupressure: The AcuOva Study – Dr. Suzie Zick
Barriers to Recommendation of Integrative Oncology Modalities in Supportive Care: A MASCC/SIO Survey – Dr. Dalia Kagramanov
Parallel Sessions
Emerging Mucosal Toxicities of New Anti-Cancer Therapies: From Pathogenesis to Management
Chairs: Prof. Hope Rugo & Prof. Sharon Elad
Presentations:
Gastrointestinal Toxicities of Immunotherapy, Tyrosine Kinase Inhibitors and Antibody Drug Conjugates – Mechanisms, Presentation, Prevention and Management – A/Prof. Christina Ruhlmann
A Sex-Dependent Salivary Bacterium Mediates Oral Mucositis After Allogeneic Transplantation – Dr. Hakan Gem
Short Talk:
Extending Cryotherapy Beyond Infusion: Real World Evidence for a Portable Intraoral Cryotherapy Device in the Prevention of Chemotherapy Associated Oral Pain – Ms. Tanya Peterson
Efficacy and Tolerability of a Portable Self-Contained Intraoral Cryotherapy Device for Mucositis Prevention: Results from the CHEM-01 Randomized Trial – Dr. Vikas Dembla
Role of AI Models in Prediction of Toxicity and Patient-related Outcomes
Chairs: Dr. Bella Van Sebille & A/Prof. Niharika Dixit
Presentations:
Using Artificial Intelligence to Predict Chemotherapy Toxicity Risk in Older Adults With Cancer – Dr. Shabbir Alibhai
Opportunities and Challenges of AI in Supportive Care – Dr. Nicole Kuderer
Integration of Real-world ePROM Data and AI to Inform Clinical Decision Making in Oncology – Prof. Janelle Yorke
How Do Patients and Clinicians Want AI to Be Used in Supportive Cancer Care? A Review From Both Literature and User Engagement – Dr. John-Jose Nunez
Impact of an AI-driven Advance Care Planning Tool on Palliative Care for Terminal Cancer Patients – Dr. Mohammad Shahinur Kabir
Immunotherapy: What is the Emerging Evidence and Guidance for Exercise as Part of Managing Toxicities?
Chairs: Prof. Nick Hart & Prof. Kristin Campbell
Presentations:
Recommendations for Cancer Patients Exercising with Central Lines: Delphi Study Update – Prof. Anna Campbell
Treatment Tolerance and Efficacy of Exercise and Immunotherapy – Dr. Ignacio Catala
Mapping the Diversity of Immunotherapy in Triple Negative Breast Cancer: Treatments, Outcomes, and Side-Effects With Immune Checkpoint Inhibitors – Prof. Nilmini Wickramasinghe
Preoperative Rehabilitation of Patients With Non-small Cell Lung Cancer – Prof. Ayako Okuyama
Patient-reported Symptoms During Pembrolizumab or Durvalumab for Lung Cancer, Compared to Randomized Trials and SmPCs – An Explorative Study – Ms. Lieke van Disseldorp
Knowledge Mobilization Product Co-design to Advance Exercise Recommendations for People With Bone Metastases – Dr. Kelcey Bland
Psychedelics and Cannabis Anyone? Opportunities and Challenges of Drug Repurposing in Management of Emerging Psychosocial Toxicities
Chairs: Prof. Joanne Bowen & Dr. Mapi Fleury
Presentations:
Psilocybin Therapy for Cancer-Related Anxiety, Depression, & Existential Distress – Prof. Anthony Back
Cannabis and Cannabinoids in Supportive Care for Cancer – Prof. Eric Roeland
Prevalence of Cannabis and Medication Use by Indices of Residential Urbanicity and Deprivation in Cancer Patients – Dr. Theodore Brasky
Patient-reported Beliefs and Preferences of Effectiveness of Medical Cannabis and Cannabidiol vs. Opioids for Management of Cancer Pain – Dr. Kimberson Tanco
Real‑World Patient Experience With Medicinal Cannabis Use for Symptom Management in Advanced Cancer: Cohort Study Using Theory of Planned Behaviour – Asst Prof. Judith Lacey
Cancer Patients Reported Beliefs and Preferences Between Medical Cannabis and Cannabidiol vs. Standard of Care Medications for Symptom Management – Dr. Kimberson Tanco
Old Drugs, New Tricks in Pain
Chairs: Dr. Akhila Reddy & Dr. Sebastiano Mercadante
Presentations:
Can Clonidine Be Used Effectively for Managing Pain and Agitation? – Prof. Mellar Davis
Exploring the Use of Olanzapine to Minimize Non-medical Opioid Use in Cancer Patients – Dr. Joseph Arthur
Efficacy of Psychological Interventions on Pain After Surgery in Breast Cancer Survivors: A Systematic Review – Ms. Samantha K. F. Kennedy
Circadian Pattern of Breakthrough Restlessness in End-of-Life Delirium: A Secondary Analysis of Two Randomized Controlled Trials – Dr. Sonal Admane
POMI Proves Insufficient as Tool to Identify Misuse of Analgesic Opioid, in Oncology Care – Prof. Virginie Guastella
ISOO Session – Collaborative Approaches in Oral Oncology
Chairs: Dr. Sophie Beaumont & Dr. Derek Smith
Presentations:
Optimising the Management of Trismus Arising From Head and Neck Cancer – Dr. Emma Charters
Exploring Radiotherapy Strategies to Prevent Trismus and Osteoradionecrosis: Clinical Insights and Future Directions – Dr. Nancy Lee
Navigating Barriers to Optimal Oral Care in Head and Neck Cancer: A Mixed-Methods Study – Mrs. Kimberly Demirhan
Effectiveness of Salivary Gland Scintigraphy to Quantitative Measurement of Xerostomia After Radiotherapy in Head and Neck Cancer – Prof. Won Sup Yoon
The Late Burden of Acute Radiation-Related Oral Toxicities: A Prospective One-Year Follow-Up Assessment – Dr. Natalia Rangel Palmier
The Hidden Role of the Nervous System in Mucositis-Associated Pain and Gastrointestinal Dysfunction Caused by Cancer Therapy
Chairs: Dr. Hannah Wardill & Dr. Akhila Reddy
Presentations:
Exploring the Neural Mechanisms of Oral Pain Associated With Mucositis – Asst. Prof. Maria Kouri
Vagalopathy and Enteric Neuropathies Associated With Gastrointestinal Dysfunction Caused by Cancer Therapies – Suzann Duan
Evaluating Causal Association of Oral Mucositis and Dysphagia – A Meta-Analysis of Randomized Clinical Trials and Comparative Effectiveness Research – Dr. Satheesh kumar Poolakkad Sankaran
Evaluation of the Relationship Between Oral Mucositis and Salivary Proteomic in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation – Miss Mariana Andrade Costa
B-vitamins and Chemotherapy-Induced Toxicities Among Patients With Colorectal Cancer – Ms. Nienke R.K. Zwart
Common and Uncommon Toxicities: Perspectives and Solutions From Patient Partners
Chairs: Dr. Maryam Lustberg & Eva Schumacher-Wulf
Panel Chair Moderator: Dr. Tingting Zhang
Additional Panelist: Diane Mapes
Presentations:
The Perpetual Consequences of Young Adult Cancer Survivorship – Scott J. Capozza
From One Therapy to the Next: Challenges, Side Effects, and Lessons Learned in Changing Cancer Treatments – Eva Schumacher-Wulf
All the Things: From Mortality to Vitality – Dr. Samantha Siegel
Enhancing Supportive Cancer Care Patient Experience: The Role of Remote Symptom Monitoring in Side Effects Management – Dr. Omolola Salako
Patient-reported Experiences of Using Electronic Patient-reported Outcome Measures (ePROMS) as Part of Routine Cancer Care – Dr. Thitikorn Nuamek
From Experience to Expertise: Strengthening Consumer Engagement to Be More Than a Conversation – Ms. Vicki Durston
Advocacy-led Co-creation to Advance Quality-of-life Research – Ms. Stacey Tinianov
Emerging Skin Toxicities of Targeted Therapy & Combination Therapy
Chair: Dr. Henry Wong
Presentations:
Balancing Skin Toxicity Risks With Clinical Cancer Benefits of Sequential Administration of Immunotherapy and Cytotoxic Agents – Dr. Satoshi Hirakawa
Short Talk: Limb Cryocompression to Reduce Chemotherapy Induced Peripheral Neuropathy – Dr. Joline Lim
Long-term Patient Reported Outcomes in a Randomized Controlled Trial of Mepitel Film Versus Standard of Care in Breast Radiation Therapy – Miss Sarah Bayrakdarian
Efficacy of Scalp Cooling in Prevention of Chemotherapy-Induced Alopecia in Children With Acute Lymphoblastic Leukemia: A Non-Ramdomized Trial – Dr. Rahul Kumar
Establishing Expert Consensus Recommendations About the Proactive Management of Dermatologic Reactions Associated with EGFR-targeted Treatments for Lung Cancer: A US Delphi Consensus Study – Dr. Anisha Patel
Financial Toxicity of Cancer Therapy: The Cost for Children
Chairs: Dr. Jason Freedman & A/Prof. Yin Ting Cheung
Presentations:
Financial Burden of Head and Neck Cancer as Experienced by Australian Patients, Their Caregivers, and Clinicians: A Qualitative Study – Ms. Ashleigh Sharman
Financial Toxicity in Adolescents and Young Adults with Cancer: Through the Lens of an AYA Survivor – Dr. Lauren Ghazal
Association of Insurance and Employment Administrative Burdens with Financial Hardship in Cancer Survivors – Dr. Salene Jones
Administrative Burden Associated With Seeking Financial Assistance During Cancer Treatment: Secondary Qualitative Analysis – Nora B. Henrikson
Importance of Mitigating Nutrition Impact Symptoms in Malnourished Patients With Advanced Cancer
Chairs: Prof. Egidio Del Fabbro & Prof. Sebastiano Mercedante
Presentations:
The Anorexia Symptom Complex and Secondary Nutritional Symptoms – Prof. Mellar Davis
Consensus Definition on Nutrition Impact Symptoms in Patients With Cancer and Association of Nutrition Impact Symptoms With Dietary Intake, Cachexia-Related Quality of Life, and Depression in Patients With Advanced Cancer – Dr. Koji Amano
Does Pre-Checkpoint Inhibitor Sarcopenia, Visceral, or Subcutaneous Fat Predict Survival in Non-Small Cell Lung Cancer Patients? – Ms. Julia Kooser
Specialized Team Management Improves Person-Centered Care for Patients Undergoing Palliative Radiotherapy – Dr. Alysa Fairchild
Associations Between On-diagnosis Nutritional Status and Muscle Wasting and Their Prognostic Role in Advanced Gastric Cancer Patients – Mr. Sang Uk Han
Assessment and Management of Loneliness in Older Adults With Cancer
Chairs: Dr. Kristen Haase & Dr. Enrique Soto Perez de Celis
Presentations:
Results of the MASCC Delphi Consensus on the Assessment of Loneliness in Older Adults with Cancer – Dr. Enrique Soto Perez de Celis
Psychosocial Interventions to Address Loneliness Among Older Adults With Cancer – Dr. Imogen Ramsey
Exploring Emotional Conversation Patterns Between Oncologists and Their Black and White Patients With Advanced Cancer – Mr. Ramana Kolady
The Gendered Experiences of Healthy Aging Among Older Adults Living With and Beyond Cancer – Ms. Ailsa Sirois
Study of Prescribing Trends During End of Life in Advanced Cancer Patients in a Comprehensive Cancer Care and Research Centre in Oman – Dr. Manisha Singh